Merck, a leading science and technology company and leader in genome editing, today announced that the United States Patent and Trademark Office has issued a formal… DARMSTADT, GERMANY Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions of the genome, increasing genome coverage Merck, a leading […]
Merck Granted U.S. Patent for novel combination of Artificial Intelligence and Blockchain Technology
Merck today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). DARMSTADT, GERMANY Patented technology provides a solution for the secure integration of physical products into the digital world Technology can protect integrity of supply chains and avoid counterfeit Merck, a leading science and technology […]
Today the European Patent Office revoked Pacific Biosciences patent EP3045542 with claims to a single molecule sequencing process wherein two strands of DNA are linked by a connecting nucleic acid. The validity of the patent had been challenged by Oxford Nanopore. The EPO ruled that the claims to a single molecule sequencing process were unsupported […]
WALTHAM, Mass. and SARASOTA, Fla. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Roper Technologies, Inc. (NYSE: ROP), a leading diversified technology company, today announced that Thermo Fisher’s pending acquisition of Gatan, Inc., a wholly owned subsidiary of Roper, requires further review by the Competition and Markets Authority (CMA) in the UK. Both parties continue […]
The proprietary TRU-E/N™ method for utmost quantification accuracy Founded by the inventors of Proton-Transfer-Reaction – Mass Spectrometry more than 20 years ago, IONICON has always been renowned for absolutely precise control of the ion chemistry during chemical ionization. ION-BOOSTER funnel and hexapole ION-GUIDE with TRU-E/N For IONICON this fact is still true even after the introduction […]
On Friday, December 7, 2018, Twist and Agilent attended a case management hearing before Judge Walsh in Santa Clara Superior Court. At the hearing, the Court set a trial date of February 24, 2020 and appointed a discovery referee. The Court also ruled on two motions filed by Agilent that had been pending for several […]
HERCULES, Calif.– A Federal District Court jury yesterday found that 10X Genomics willfully infringed three United States patents owned by the University of Chicago and exclusively licensed to Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products (NYSE: BIO and BIOb). In awarding Bio-Rad $23.9 million in damages, the jury unanimously […]
SAN DIEGOT Allele Biotechnology & Pharmaceuticals Inc. has received issuance notices from the U.S. Patent and Trademark Office for its first batch of patents covering the derivation of induced pluripotent stem cells (iPSCs). Allele’s proprietary technology uses only messenger RNA (mRNA) to reprogram human or other primate cells, avoiding many operational complications that other methods […]
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that it sent a letter to the Division of Corporation Finance of the U.S. Securities and Exchange Commission (SEC) regarding misstatements in the S-1 Registration Statement filed by Twist Bioscience Corp. The letter informs the SEC that “Twist’s S-1 Fails to Disclose that Twist CEO […]
This is the 31st DART-related patent for IonSense and further strengthens its position in ambient ionization. The invention enables high-throughput screening of drugs of abuse. SAUGUS, Mass. — IonSense, Inc. has announced that the U.S. Patent and Trademark Office has issued a patent related to its Direct Analysis in Real Time (DART®) mass spectrometry technology. […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
